Anti-B7-2-gelonin immunotoxin

Drug Profile

Anti-B7-2-gelonin immunotoxin

Alternative Names: Anti-B7-2 monoclonal antibody-gelonin immunotoxin conjugate; B7-2 targeted immunotoxin

Latest Information Update: 03 Sep 2002

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Antineoplastics; Immunotoxins; Monoclonal antibodies
  • Mechanism of Action CD86 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 04 May 1999 New profile
  • 04 May 1999 Preclinical development for Cancer in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top